Patryk Sobieralski to Humans
This is a "connection" page, showing publications Patryk Sobieralski has written about Humans.
Connection Strength
0.116
-
Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT. Bone Marrow Transplant. 2026 01; 61(1):36-43.
Score: 0.025
-
Polycythemia vera and essential thrombocythemia of intermediate-age: A real-life, multicenter analysis of first-line treatment approach. Adv Clin Exp Med. 2025 Jan; 34(1):25-32.
Score: 0.024
-
Secondary chronic myeloid leukemia in a patient with CALR and ASXL1-mutated primary myelofibrosis. Int J Hematol. 2022 Sep; 116(3):442-445.
Score: 0.020
-
Late polycythemic transformation in JAK2-mutated essential thrombocythemia patients-characteristics along with a validation of 2016 WHO criteria. Eur J Haematol. 2019 Dec; 103(6):558-563.
Score: 0.016
-
Donor cell-derived haematological neoplasms after allogeneic haematopoietic cell transplantation: recommendations from the EBMT Practice Harmonisation and Guidelines Committee. Lancet Haematol. 2026 Jun; 13(6):e408-e417.
Score: 0.007
-
Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee. Bone Marrow Transplant. 2026 May; 61(5):591-600.
Score: 0.006
-
Myeloproliferative neoplasms with concomitant chronic myeloid leukemia are associated with TKI resistance and poor outcomes. Leukemia. 2026 May; 40(5):946-954.
Score: 0.006
-
A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm. Bone Marrow Transplant. 2026 03; 61(3):333-340.
Score: 0.006
-
Anagrelide in essential thrombocythemia: Efficacy and long-term consequences in young patient population. Leuk Res. 2022 12; 123:106962.
Score: 0.005